510(k) Report

510(k) · Cleared

Cleared

TMD 1ML Safety Syringe (FA11 Series 1ML/FA51 Series U-100 Insulin/FA71 Series Tuberculin)

K031062510(k) SpecialCleared May 2, 200329-day reviewClass II21 CFR 880.5860

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Taiject Medical Device Co., Ltd. · MEG Syringe, Antistick

Cleared on May 2, 2003 as substantially equivalent to K022278 (Taiject Medical Device Co., Ltd., 2002) and 1 other predicate after a 29-day review. Its family tree reaches back 2 generations to 2002. 1 later device descends from it.

Decided
May 2, 2003
Review
29 days
Class
Class II
Product code
MEG
Recalls
None
Predicates
2

Its longest line of descent runs back 2 generations to K022278 (2002). 1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2004: 1 descendant cleared×2: 2 generations cleared close together, K022278 (2002), K023458 (2002) 200020052010201520202025
  1. Root · 2 generations backK022278 TMD Safety Syringe (FA12 Series 3ML/FA13 Series 5ML)Taiject Medical Device Co., Ltd. · 2002
  2. 1 generation backK023458 TMD Safety Syringe (FA14 Series 10ML/FA15 Series 20ML)Taiject Medical Device Co., Ltd. · 2002
  3. This deviceK031062 TMD 1ML Safety Syringe (FA11 Series 1ML/FA51 Series U-100…Taiject Medical Device Co., Ltd. · 2003
  4. Descendant · cites it directly · 0 of its ownK042426 TMD 0.5ML Safety Syringe (FA18 Series 0.5ML/FA58 Series U-100…Taiject Medical Device Co., Ltd. · 2004

Most influential descendants

Showing 1 of 1 · See all
  • K042426TMD 0.5ML Safety Syringe (FA18 Series 0.5ML/FA58 Series U-100 Insulin/FA78 Series…Taiject Medical Device Co., Ltd. · 2004 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K022278TMD Safety Syringe (FA12 Series 3ML/FA13 Series 5ML)Taiject Medical Device Co., Ltd.2002—
−1K023458TMD Safety Syringe (FA14 Series 10ML/FA15 Series 20ML)Taiject Medical Device Co., Ltd.2002—
0 (this device)K031062TMD 1ML Safety Syringe (FA11 Series 1ML/FA51 Series U-100 Insulin/FA71 Series…Taiject Medical Device Co., Ltd.2003—
+1K042426TMD 0.5ML Safety Syringe (FA18 Series 0.5ML/FA58 Series U-100 Insulin/FA78…Taiject Medical Device Co., Ltd.2004—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200410
FIG. 1 — Lineage of K031062, 2002–2004Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MEG? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MEG device

  1. #1 K192551 1ml Luer Slip or Luer Lock Syringe, Syringe…score 19.6 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K022278TMD Safety Syringe (FA12 Series 3ML/FA13 Series 5ML)
Summary page 2
…ti-Stick Syringe (MEG) 3. Predicate Device (Legally Marketed Device): Legally Marketed Device: TMD™ Safety Syringe (FA12 Series 3 mI/FA13 Series 5 ml) with 510K number K022278. 4. DEVICE DESCRIPTION The TMD™ 1ml Safety Syringe (FA11 Series 1mI/FA51 Series U-100 Insulin / FA71 Series Tuberculin) is a si…
Taiject Medical Device Co., Ltd.2002—
*K023458TMD Safety Syringe (FA14 Series 10ML/FA15 Series 20ML)
Summary page 3
…device, TMD™ Safety Syringe (FA12 Series 3 mI/FA13 Series 5 ml) with 510K number K022278 and TMD™ Safety Syringe (FA14 Series 10 mV/FA15 Series 20 ml) with 510K number K023458. 7. PERFORMANCE DATA Performance data has been generated in compliance with the design control requirement and appropriate sta…
Taiject Medical Device Co., Ltd.2002—

Also cleared against K022278: 4 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K042426TMD 0.5ML Safety Syringe (FA18 Series 0.5ML/FA58 Series U-100 Insulin/FA78 Series…Taiject Medical Device Co., Ltd.20040

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 1 year and passes through 1 company; a new generation was cleared every 6 months on median.
  • None of the 2 ancestors has a recall.
  • Of its descendants, K042426 (Taiject Medical Device Co., Ltd., 2004) has gone furthest, with 0 descendants of its own.
  • 4 other devices also cite its predicate K022278.

How does its category compare?

All MEG devices

MEG Syringe, Antistick: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · MEG

1in 2025

2007: 82008: 42009: 22010: 22011: 52012: 52013: 12014: 52015: 72016: 32017: 32018: 12019: 42020: 42021: 52022: 132023: 52025: 12026 (partial year): 1
2007high 13 (2022) · low 0 (2024)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MEG

229in 2023

2007: 100 days median2008: 145 days median2011: 113 days median2012: 109 days median2014: 153 days median2015: 253 days median2016: 179 days median2017: 130 days median2019: 249 days median2020: 296 days median2021: 152 days median2022: 216 days median2023: 229 days median
2007high 296 (2020) · low 100 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MEG

1in 2024

2008: 12010: 12013: 52015: 12024: 1, 1 Class I
2007high 5 (2013) · low 0 (2007)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · MEG

148in 2025

2007: 212008: 202009: 262010: 342011: 342012: 222013: 272014: 362015: 512016: 942017: 1812018: 2692019: 4972020: 3532021: 5412022: 1702023: 1202024: 1122025: 148
2007high 541 (2021) · low 20 (2008)2025

MAUDE reports naming product code MEG, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20078100021
20084145120
20092—026
20102—134
20115113034
20125109022
20131—527
20145153036
20157253151
20163179094
201731300181
20181—0269
201942490497
202042960353
202151520541
2022132160170
202352290120
20240—1 (1)112
20251—0148
20261—0—

What is it indicated for?

The TMD™ 1ml Safety Syringe (FA11 Series 1ml) is intended for injection of fluids into the body after the aspiration of fluid.

The TMD™ 1ml Insulin Safety Syringe (FA51 Series U-100 Insulin) is intended for use for subcutaneous injection of Insulin.

The TMD™ 1ml Tuberculin Safety Syringe (FA71 Series Tuberculin) is intended for intra-dermal injection of Tuberculin.

All the three syringes above incorporate a safety feature that is designed to aid the reduction of needlestick injuries and the potential of syringe reuse.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K031062: TMD 1ML Safety Syringe (FA11 Series 1ML/FA51 Series U-100 Insulin/FA71 Series Tuberculin).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K031062

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026